| Literature DB >> 35095797 |
Brandon Robin1, Marion Nicol1, Hung Le1, Ali Tahrioui2, Annick Schaumann1,3, Jean-Baptiste Vuillemenot4, Delphine Vergoz1, Olivier Lesouhaitier2, Thierry Jouenne1,3, Julie Hardouin1,3, Anaïs Potron4, Valérie Perrot1, Emmanuelle Dé1.
Abstract
Acinetobacter baumannii has emerged as one of the most problematic bacterial pathogens responsible for hospital-acquired and community infections worldwide. Besides its high capacity to acquire antibiotic resistance mechanisms, it also presents high adhesion abilities on inert and living surfaces leading to biofilm development. This lifestyle confers additional protection against various treatments and allows it to persist for long periods in various hospital niches. Due to their remarkable antimicrobial tolerance, A. baumannii biofilms are difficult to control and ultimately eradicate. Further insights into the mechanism of biofilm development will help to overcome this challenge and to develop novel antibiofilm strategies. To unravel critical determinants of this sessile lifestyle, the proteomic profiles of two A. baumannii strains (ATTC17978 and SDF) grown in planktonic stationary phase or in mature solid-liquid (S-L) biofilm were compared using a semiquantitative proteomic study. Of interest, among the 69 common proteins determinants accumulated in the two strains at the S-L interface, we sorted out the MacAB-TolC system. This tripartite efflux pump played a role in A. baumannii biofilm formation as demonstrated by using ΔmacAB-tolC deletion mutant. Complementary approaches allowed us to get an overview of the impact of macAB-tolC deletion in A. baumannii physiology. Indeed, this efflux pump appeared to be involved in the envelope stress response occurring in mature biofilm. It contributes to maintain wild type (WT) membrane rigidity and provides tolerance to high osmolarity conditions. In addition, this system is probably involved in the maintenance of iron and sulfur homeostasis. MacAB-TolC might help this pathogen face and adapt to deleterious conditions occurring in mature biofilms. Increasing our knowledge of A. baumannii biofilm formation will undoubtedly help us develop new therapeutic strategies to tackle this emerging threat to human health.Entities:
Keywords: biofilm; eDNA; efflux pump; envelop stress response; solid–liquid interface
Year: 2022 PMID: 35095797 PMCID: PMC8792954 DOI: 10.3389/fmicb.2021.785161
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Proteomic analyses of solid–liquid (S-L) biofilms formed by A. baumannii ATCC 17978 and SDF strains compared to their planktonic counterparts. (A) Number of proteins identified by proteomic analyses of A. baumannii ATCC 17978 and SDF strains and number of proteins with modified abundance in S-L biofilms compared to their planktonic counterparts. (B) Classification of these differentially represented proteins from A. baumannii SDF (left) and ATCC 17978 (right) according to their biological processes using the kyoto encyclopedia of genes and genomes (KEGG) pathway.
FIGURE 2Impact of the macAB-tolC deletion on A. baumannii biofilm formation at the solid–liquid interface. (A) Biomass quantification by crystal violet staining of A. baumannii ATCC 17978 wild type (WT), ΔMac, and ΔMac_c (ΔMac complemented strain). (B) Quantification of biovolume (μm3/μm2) of A. baumannii ATCC 17978 WT and ΔMac biofilms based on the confocal fluorescence images. (C) Representative confocal laser scanning microscopy (CLSM) images of A. baumannii ATCC 17978 WT (left) and ΔMac biofilms (right) labeled with Syto9. Data shown represent mean values (±SD) from at least three independent biological experiments (ns, not significant; *p < 0.05; **p < 0.01). Scale bar: 20 μm. OD, optical density.
FIGURE 3Impact of macAB-tolC deletion on biofilm formation at the solid-liquid-air interface. (A) Total biovolume (μm3/μm2) of 24-h-old A. baumannii ATCC 17978 WT and ΔMac biofilms after exposure to DNase I (100 μg/ml) compared to untreated control biofilms. Quantification of biovolume was based on the confocal fluorescence images of Syto9 stained biofilms. Data shown represent mean values (±SD) from at least three independent biological experiments (ns, not significant; *p < 0.05; **p < 0.01). (B) Representative confocal fluorescence images of A. baumannii ATCC 17978 WT (left) and ΔMac biofilms (right) labeled with Syto9 at the solid–liquid–air interface (three-phase interface). Image construction was carried out using Imaris software. Scale bar: 10 μm.
FIGURE 4Tolerance to sucrose and membrane fluidity analyses of WT vs. ΔMac and ΔMac_c derivative strains of A. baumannii. (A) The 24 h growth measurements in high-osmolarity condition (500 mM sucrose). (B) Fluorescence anisotropy measurements of planktonic (PLK) growth culture (24 h; clear gray) or biofilm (BF) growth culture (48 h; dark gray). Data shown represent mean values (±SD) from at least three independent experiments. The data were statistically analyzed using unpaired t-test to calculate p-values (ns, not significant; *p < 0.05; **p < 0.01; ***p < 0.001). CFU/mL, colony-forming unit per ml.
Proteins under-represented in solid–liquid biofilm of ΔMac.
| Label ABYAL | Label A1S_ | Fold change | Gene | Description | Fraction | Peptides | Confidence | Anova ( |
|
| ||||||||
| ABYAL0571 | A1S_0535 | 18.0 |
| Outer membrane protein | M | 2 | 89.64 | 1.1E-03 |
| ABYAL0574 | A1S_0538 | 12.9 |
| ABC tripartite efflux pump membrane fusion protein | M | 5 | 216.38 | 1.5E-10 |
|
| ||||||||
| ABYAL1976 | A1S_1657 | 2.6 |
| Baumannoferrin biosynthesis protein | I | 3 | 137.34 | 5.1E-03 |
| ABYAL2846 | A1S_2375 | 3.1 |
| Siderophore ABC transporter | M | 13 | 716.65 | 1.6E-03 |
| ABYAL2852 | A1S_2380 | 3.2 |
| Isochorismatase | I+M | 3 | 109.43 | 3.8E-03 |
| ABYAL2853 | A1S_2381 | 2.8 |
| 2,3-Dihydroxybenzoate-AMP ligase/S-dihydroxybenzoyltransferase | I | 2 | 168.79 | 5.1E-03 |
| ABYAL2858 | A1S_2386 | 2.3 |
| Acinetobactin periplasmic binding protein | M | 7 | 389.76 | 7.5E-03 |
| ABYAL2863 | A1S_2390 | 2.3 |
| Acinetobactin biosynthesis protein | M | 3 | 161.11 | 7.6E-03 |
|
| ||||||||
| ABYAL0038 | A1S_0028 | 2.2 |
| FMNH(2)-dependent alkanesulfonate monooxygenase | I+M | 4 | 202.00 | 3.4E-03 |
| ABYAL0039 | A1S_0029 | 2.5 |
| Aliphatic sulfonate ABC transporter periplasmic | M | 2 | 103.65 | 4.2E-04 |
| ABYAL0040 | A1S_0030 | 2.5 |
| Aliphatic sulfonate ABC transporter periplasmic | M | 2 | 88.15 | 1.3E-03 |
| ABYAL3025 | A1S_2537 | 2.3 |
| DNA-binding transcriptional activator (LysR-family) | M | 3 | 147.98 | 2.1E-04 |
| ABYAL3888 | A1S_3305 | 2.1 |
| NADH-dependent FMN reductase | M | 2 | 96.85 | 3.7E-03 |
| ABYAL3889 | A1S_3306 | 3.1 |
| FMNH(2)-dependent dimethylsulfone monooxygenase | I+M | 4 | 259.99 | 3.8E-04 |
| ABYAL1751 | A1S_1485 | 2.4 |
| Methionine ABC transporter permease | M | 8 | 392.49 | 4.3E-04 |
|
| ||||||||
| ABYAL1576 | A1S_1335 | 15.2 |
| Oxepin-CoA hydrolase/dehydrosuberyl-CoA semialdehyde dehydrogenase | I+M | 5 | 221.52 | 4.9E-03 |
| ABYAL1577 | A1S_1336 | 9.6 |
| 1,2-phenylacetyl-CoA epoxidase subunit A | I | 3 | 113.1 | 7.7E-04 |
| ABYAL1583 | A1S_1342 | 9.2 |
| 2-(1,2-epoxy-1.2-dihydrophenyl)acetyl-CoA isomerase | I+M | 8 | 394.61 | 3.1E-03 |
| ABYAL1584 | A1S_1343 | 9.6 |
| 3-hydroxybutyryl-CoA dehydrogenase | I | 3 | 178.95 | 2.6E-03 |
| ABYAL1585 | A1S_1344 | 12.4 |
| Beta-ketoadipyl-CoA thiolase | I | 2 | 123.36 | 6.4E-03 |
|
| ||||||||
| ABYAL1534 | A1S_1296 | 2.5 |
| Type VI secretion system effector | M | 14 | 1017.28 | 2.6E-07 |
| ABYAL3106 | A1S_2602 | 4.1 |
| Rhombotarget A | M | 3 | 102.26 | 3.2E-04 |
|
| ||||||||
| ABYAL0608 | A1S_0569 | 2.0 | Short-chain dehydrogenase/reductase | M | 2 | 86.33 | 1.1E-03 | |
| ABYAL1300 | A1S_1126 | 3.6 | Baeyer–Villiger monooxygenase | M | 3 | 149.25 | 1.5E-04 | |
| ABYAL1493 | A1S_1264 | 2.2 | Class A β-lactamase-related serine hydrolase | M | 2 | 105.9 | 1.4E-03 | |
| ABYAL1530 | A1S_1292 | 2.4 | Conserved hypothetical protein | M | 2 | 48.99 | 3.4E-05 | |
| ABYAL1698 | A1S_1439 | 2.3 | Luciferase-like monooxygenase | I | 2 | 129.35 | 9.8E-05 | |
| ABYAL1742 | A1S_1478 | 2.4 | Conserved hypothetical protein | I | 3 | 128.33 | 9.3E-05 | |
| ABYAL1831 | A1S_1551 | 2.1 |
| ATPase chromosome partitioning protein | M | 2 | 127.04 | 8.0E-05 |
| ABYAL2029 | A1S_1700 | 2.0 |
| Acetoin:2,6-dichlorophenolindophenol oxidoreductase beta subunit | M | 2 | 127.54 | 1.5E-03 |
| ABYAL2289 | A1S_1922 | 2.5 | Ribokinase | M | 2 | 96.2 | 3.3E-04 | |
| ABYAL2361 | 2.2 | Conserved hypothetical protein | I | 3 | 127.91 | 2.2E-03 | ||
| ABYAL2518 | A1S_2084 | 3.4 |
| Secreted chorismate mutase | M | 3 | 180.53 | 1.8E-05 |
| ABYAL2931 | A1S_2452 | 3.6 |
| Phenylacetaldehyde dehydrogenase | I+M | 8 | 448.54 | 1.3E-04 |
| ABYAL3342 | A1S_2820 | 2.8 | Conserved hypothetical protein | I | 2 | 122.24 | 1.7E-03 | |
| ABYAL3515 | A1S_2957 | 2.2 | Zn-dependent hydrolase | M | 2 | 101.57 | 2.3E-05 | |
| ABYAL4020 | A1S_3418 | 2.7 |
| 4-hydroxyphenylpyruvate dioxygenase | I | 4 | 210.88 | 6.0E-03 |
“M” for membrane fraction and “I” for intracellular fraction.
Over-represented proteins in solid–liquid biofilm of ΔMac.
| Label ABYAL | Label A1S_ | Fold change | Gene | Description | Fraction | Peptides | Confidence | Anova ( |
|
| ||||||||
| ABYAL0138 | A1S_0115 | 2.7 | Non-ribosomal peptide synthetase (NRPS) | I | 2 | 93.95 | 9.4E-04 | |
| ABYAL0139 | A1S_0116 | 2.3 | Resistance-nodulation-division (RND) transporter (Ac-505 secretion) | M | 5 | 259.28 | 2.0E-03 | |
|
| ||||||||
| ABYAL1401 | A1S_1191 | 2.1 |
| Aspartate carbamoyltransferase | M | 4 | 214.67 | 1.6E-03 |
| ABYAL1402 | A1S_1192 | 2.3 |
| Aspartate carbamoyltransferase | M | 2 | 169.65 | 4.2E-05 |
| ABYAL1640 | A1S_1387 | 2.0 |
| Short-chain dehydrogenase reductase | M | 2 | 56.02 | 9.3E-03 |
| ABYAL2806 | A1S_2338 | 2.2 |
| Malate dehydrogenase | M | 20 | 1084.58 | 2.4E-05 |
| ABYAL2984 | A1S_2501 | 2.2 |
| Glyceraldehyde-3-phosphate dehydrogenase | I | 2 | 97.82 | 1.3E-05 |
| ABYAL3089 | A1S_2586 | 2.0 |
| Deoxyguanosinetriphosphate triphosphohydrolase-like protein | M | 2 | 92.13 | 6.3E-04 |
| ABYAL3806 | A1S_3231 | 2.7 |
| Succinyl-CoA coenzyme A transferase | I | 2 | 97.74 | 4.1E-06 |
| ABYAL3914 | A1S_3327 | 2.2 |
| Dihydrolipoamide acyltransferase (E2) component | M | 10 | 587.81 | 2.8E-05 |
| ABYAL4005 | A1S_3403 | 2.0 |
| Imidazolonepropionase | I | 3 | 147.31 | 1.0E-04 |
“M” for membrane fraction and “I” for intracellular fraction.
FIGURE 5Adhesion of A. baumannii to A549 human alveolar epithelial cells. (A) ATII-like phenotype A549 differentiated cells were infected with A. baumannii ATCC 17978 (WT), ΔMac, and ΔMac_c (ΔMac complemented) at a multiplicity of infection (MOI) of 20. Negative control corresponds to cells with no bacteria added. Black arrows indicate bacteria attached to A549 cells (magnification, ×400). (B) Quantification of the adherence of A. baumannii ATCC 17978 WT, ΔMac, and ΔMac_c strains to A549 cells. Index of attached bacteria after 24 h of infection. Data shown represent mean values (±SD) from at least three independent experiments performed at least in triplicate. Student’s t-test was used to validate the experimental data (ns, not significant; ****p < 0.0001).